February 2009 Editor's Picks: Products from Oystar USA and Schreiner MediPharm - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

February 2009 Editor's Picks: Products from Oystar USA and Schreiner MediPharm


Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

product Oystar USA
Press produces multilayer tablets

Oystar USA (Fairfield, NJ) offers its “FlexiTab” fully automated, single-station tablet press for small-batch production. The machine features a multilayer-tablet function to produce three-layer tablets.

The FlexiTab device is not fixed to a compression cycle, unlike other tablet presses. Parameters such as tablet weight, force, dwell, and thickness are adjustable through the unit’s touch-screen panel control system. The press’s hydraulic and pneumatic cylinders achieve compression forces as great as 100 kN and enable rapid punch displacement. Operators can thus simulate various rotary tablet presses at various speeds.

In addition to enabling the compression cycle to be modified, the FlexiTab unit’s computer and software can store compression-profile and tooling-list data. The machine uses standard Euro B and D tooling and can be operated in setup, series, step-by-step, and manual modes.



productSchreiner MediPharm
Label system helps prevent injuries

The “Needle-Trap” system from Schreiner MediPharm (Blauvelt, NY) is a label for disposable syringes designed to protect healthcare providers from accidental needlestick injuries. The system comprises a self-adhesive syringe label with an integrated safety mechanism that secures the needle. Healthcare providers can easily uncover the needle to deliver an injection and secure it afterward, without altering their injection technique.

The Needle-Trap labels can be incorporated into common pharmaceutical labeling systems easily. The product is also available with optional detachable documentation labels intended to reduce the risk of medication errors. The labels can be adapted to the most common syringe types.

The system’s easy integration, flexibility, and process reliability make it a suitable solution for pharmaceutical manufacturers, according to the company. In addition, the Needle-Trap system meets healthcare professionals’ requirements for field-use safety.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Equipment and Processing Report,
Click here